Compare CDMOs manufacturing lyophilized drug products for biologics, peptides, and injectable pharmaceuticals. Filter by dryer capacity, cycle development expertise, and scale.
128 companies listed
Lyophilized (freeze-dried) products are manufactured by removing water from a drug formulation through sublimation, producing a stable dry cake that is reconstituted before use. This dosage form is essential for biologics, peptides, and other molecules that are unstable in liquid form. The lyophilization process occurs after aseptic vial filling, making it an integrated part of the sterile manufacturing process.
Key CDMO selection criteria for lyophilized products include: cycle development expertise (thermal analysis, process optimization), dryer capacity (shelf area determines batch size), scale-up capability (lab to commercial dryers), and integrated fill-finish services. CDMOs offering end-to-end fill-lyophilize-inspect services eliminate the logistics complexity of shipping partially stoppered vials between facilities.
Japan
PeptiStar is a Japan-based CDMO specializing in the development and cGMP manufacture of peptide and oligonucleotide APIs. From its 10,500 m² R&D and manufacturing site in Settsu, Osaka, the company supports programs from milligram-scale research material through clinical and commercial production. PeptiStar works with complex peptide structures, including long-chain, cyclic, branched and constrained peptides, non-natural amino acids and peptide conjugates. Its route-flexible manufacturing platform includes conventional and microwave-assisted SPPS, STag-PS and SYNCSOL liquid-phase technologies. Integrated downstream capabilities include preparative and continuous chromatography, membrane concentration and lyophilization, with 300 L filter reactors, chromatography columns up to 450 mm and lyophilizers up to 500 L. Purification and subsequent processing are conducted in Class 100,000 controlled areas. PeptiStar also develops and manufactures oligonucleotide APIs and peptide–oligonucleotide conjugates. The company was recognised by Exelixis as its 2025 CDMO of the Year.
Our AI Matchmaker analyzes your project requirements and matches you with qualified manufacturing partners. Free for buyers.
Germany
Vetter Pharma is a leading global Contract Development and Manufacturing Organization specializing in aseptic fill-and-finish services for injectable drug products. Headquartered in Ravensburg, Germany, Vetter operates as an independent, family-owned business with over 75 years of experience.